The webcast presentation will take place at 1:15 p.m. ET on Tuesday, September 30, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/fall2025/ or ...
SEATTLE, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced the acceptance of two oral presentations at the upcoming European Society of Gene ...
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System. INBS anticipates FDA 510(k) clearance in the second half of 2026.
New Clue Survey Reveals Misinformation About Reproductive Health is a Top Concern for American Women
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- New data released today reveals medical misinformation about reproductive health is a major concern for 82% of U.S. women* with more than 1 in 2 saying ...
The Gala will feature moving patient stories, captivating artistic performances, commemorative videos, gourmet dining, and inspiring encounters with current and former patients— all in celebration of ...
This award strongly validates our approach to Alzheimer’s disease,” said Dr. Carmela Abraham, Chief Science Officer. “With NIH support, we are one step closer to helping patients suffering from this ...
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt ...
CT imaging is the foundation of precision in radiation therapy planning, delivering accuracy to guide treatment. But as oncology teams face mounting demands for precision, efficiency, and consistency ...
CARSON CITY, Nev., Sept. 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and ...
Andrew Oakley, Chairman of the Board of Onconetix, added: "Ocuvex is an innovative company with a strong commitment to advancing eye health. Despite our decision to part ways, we are confident that ...
Mr. Amar brings to SS Innovations more than 25 years of global finance leadership experience spanning a wide range of industries and geographies. During his career, he has amassed expertise in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback